Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality (original) (raw)
MP14-08 the Incidence of Treatment-Related Complications with Contemporary Treatment for Clinically-Localized Prostate Cancer
Ashraf Almatar
The Journal of Urology, 2015
View PDFchevron_right
Management of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia in Real-life Practice in France: A Comprehensive Population Study
Bertrand Lukacs, Natacha Tessier
European Urology, 2013
View PDFchevron_right
Prostate cancer, treatment modalities and complications: an evaluation of the scientific literature
Sebastiao David Santos Filho
Brazilian Archives of Biology and Technology, 2008
View PDFchevron_right
The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trial
Johan Stranne
European Journal of Cancer, 2011
View PDFchevron_right
Normal urinary and sexual function in men without evidence of prostate cancer from Montreal, Canada
Alvaro Ramirez
Bju International, 2006
View PDFchevron_right
Prostate-specific symptoms of prostate cancer in a German general population
Thomas Kuechler
Prostate Cancer and Prostatic Diseases, 2007
View PDFchevron_right
Prostate cancer treatment in Europe at the end of 1990s
I. Plesko, Paolo Contiero
Acta Oncologica, 2009
View PDFchevron_right
A cohort study reporting clinical risk factors and individual risk perceptions of prostate cancer: implications for PSA testing
Daniel Kelly
BJU …, 2012
View PDFchevron_right
Consensus statement on definition, diagnosis, and management of high-risk prostate cancer patients on behalf of the Spanish Groups of Uro-Oncology Societies URONCOR, GUO, and SOGUG
Iván Henríquez
Clinical and Translational Oncology, 2017
View PDFchevron_right
Progression of Null or Mild Lower Urinary Tract Symptoms Indicative of Benign Prostatic Hyperplasia After 2 Years of Follow-up in Non-treated Men Aged 40 Years or Older
Jesús Moreno-Sierra
Urology, 2011
View PDFchevron_right
Actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia: temporal trends of prescription and hospitalization rates over 5 years in a large population of Italian men
Caterina Fanizza
International Urology and Nephrology, 2013
View PDFchevron_right
Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2007 and 2013: status from a Danish primary referral center
Klaus Brasso
Acta oncologica (Stockholm, Sweden), 2016
View PDFchevron_right
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)
Vincent Molinié
British journal of cancer, 2003
View PDFchevron_right
Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise
emmanuel chartier-kastler
Prostate Cancer and Prostatic Diseases, 2005
View PDFchevron_right
Epidemiology of prostate cancer and treatment remarks
Giorgio Arcangeli
World Journal of Radiology, 2012
View PDFchevron_right
Does Management of Erectile Dysfunction after Radical Prostatectomy Meet Patients' Expectations? Results of a National Survey (REPAIR) by the French Urological Association
emmanuel chartier-kastler
The Journal of Sexual Medicine, 2008
View PDFchevron_right
Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
Ger van Venrooij
Urology, 2001
View PDFchevron_right
Treatment of Incidental Prostate Cancer Diagnosed during BPH Surgery with Radical Prostatectomy: Appropriate or over Treatment?
Haluk ÖZEN
Journal of Cancer Therapy, 2012
View PDFchevron_right
How Urologists Manage Erectile Dysfunction after Radical Prostatectomy: A National Survey (REPAIR) by the French Urological Association
emmanuel chartier-kastler
The Journal of Sexual Medicine, 2007
View PDFchevron_right
Baseline Prevalence of Erectile Dysfunction in a Prostate Cancer Screening Population
Paul Perrotte
Journal of Sexual Medicine, 2007
View PDFchevron_right
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment
Sharon Phillips
Cancer, 2014
View PDFchevron_right
Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO.it
M. Perachino
Therapeutic Advances in Urology, 2012
View PDFchevron_right
1010 Under-treatment of men in their seventies with high risk, non-metastatic prostate cancer
marie Hjälm-Eriksson
European Urology Supplements, 2015
View PDFchevron_right